TER vs TERN · P/E 76, rev $2.82B vs $6.12B cap
Teradyne Inc (TER) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
TER currently screens at market cap $63.96B and trailing P/E 75.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the TER and TERN stock pages for the full models.
Not investment advice.